Skip Navigation LinksHome > April 2008 - Volume 36 - Issue 4 > The costs and cost-effectiveness of an integrated sepsis tre...
Critical Care Medicine:
doi: 10.1097/CCM.0b013e318168f649
Clinical Investigations

The costs and cost-effectiveness of an integrated sepsis treatment protocol

Talmor, Daniel MD, MPH; Greenberg, Dan PhD; Howell, Michael D. MD; Lisbon, Alan MD; Novack, Victor MD, PhD; Shapiro, Nathan MD, MPH

Collapse Box

Abstract

Context: Sepsis is associated with high mortality and treatment costs. International guidelines recommend the implementation of integrated sepsis protocols; however, the true cost and cost-effectiveness of these are unknown.

Objective: To assess the cost-effectiveness of an integrated sepsis protocol, as compared with conventional care.

Design: Prospective cohort study of consecutive patients presenting with septic shock and enrolled in the institution's integrated sepsis protocol. Clinical and economic outcomes were compared with a historical control cohort.

Setting: Beth Israel Deaconess Medical Center.

Patients: Overall, 79 patients presenting to the emergency department with septic shock in the treatment cohort and 51 patients in the control group.

Interventions: An integrated sepsis treatment protocol incorporating empirical antibiotics, early goal-directed therapy, intensive insulin therapy, lung-protective ventilation, and consideration for drotrecogin alfa and steroid therapy.

Main Outcome Measures: In-hospital treatment costs were collected using the hospital's detailed accounting system. The cost-effectiveness analysis was performed from the perspective of the healthcare system using a lifetime horizon. The primary end point for the cost-effectiveness analysis was the incremental cost per quality-adjusted life year gained.

Results: Mortality in the treatment group was 20.3% vs. 29.4% in the control group (p = .23). Implementing an integrated sepsis protocol resulted in a mean increase in cost of ∼$8,800 per patient, largely driven by increased intensive care unit length of stay. Life expectancy and quality-adjusted life years were higher in the treatment group; 0.78 and 0.54, respectively. The protocol was associated with an incremental cost of $11,274 per life-year saved and a cost of $16,309 per quality-adjusted life year gained.

Conclusions: In patients with septic shock, an integrated sepsis protocol, although not cost-saving, appears to be cost-effective and compares very favorably to other commonly delivered acute care interventions.

© 2008 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.